IBDEI0BH ; ; 01-AUG-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4,979,0)
;;=INFECTIOUS DISEASE^10^74
;;^UTILITY(U,$J,358.4,980,0)
;;=INTERSTITIAL LUNG DISEASE^11^74
;;^UTILITY(U,$J,358.4,981,0)
;;=MUSCULOSKELETAL^12^74
;;^UTILITY(U,$J,358.4,982,0)
;;=SUTURES^24^74
;;^UTILITY(U,$J,358.4,983,0)
;;=RADIATION^20^74
;;^UTILITY(U,$J,358.4,984,0)
;;=OCCUPATIONAL^16^74
;;^UTILITY(U,$J,358.4,985,0)
;;=PAIN^17^74
;;^UTILITY(U,$J,358.4,986,0)
;;=PLEURAL DISEASE^18^74
;;^UTILITY(U,$J,358.4,987,0)
;;=PSYCHIATRIC/BEHAVIORAL^19^74
;;^UTILITY(U,$J,358.4,988,0)
;;=SKIN^21^74
;;^UTILITY(U,$J,358.4,989,0)
;;=NEUROLOGIC^13^74
;;^UTILITY(U,$J,358.4,990,0)
;;=OBSTRUCTIVE DISEASE^14^74
;;^UTILITY(U,$J,358.4,991,0)
;;=VASCULAR^26^74
;;^UTILITY(U,$J,358.4,992,0)
;;=SYMPTOMS^25^74
;;^UTILITY(U,$J,358.4,993,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^23^74
;;^UTILITY(U,$J,358.4,994,0)
;;=VACCINATIONS^12^75
;;^UTILITY(U,$J,358.4,995,0)
;;=INJECTION^5^75
;;^UTILITY(U,$J,358.4,996,0)
;;=EDUCATION/TRAINING^3^75
;;^UTILITY(U,$J,358.4,997,0)
;;=COUNSELING^2^75
;;^UTILITY(U,$J,358.4,998,0)
;;=EVALUATIONS^4^75
;;^UTILITY(U,$J,358.4,999,0)
;;=SPINAL INJECTION CODES^8^75
;;^UTILITY(U,$J,358.4,1000,0)
;;=SUPPLIES^9^75
;;^UTILITY(U,$J,358.4,1001,0)
;;=TREATMENT PROCEDURES^10^75
;;^UTILITY(U,$J,358.4,1002,0)
;;=TRIGGER POINT INJECTIONS^11^75
;;^UTILITY(U,$J,358.4,1003,0)
;;=ACUPUNCTURE^1^75
;;^UTILITY(U,$J,358.4,1004,0)
;;=NAILS^7^75
;;^UTILITY(U,$J,358.4,1005,0)
;;=INTRATHECAL BACLOFED PUMP REFILL/ADJ^6^75
;;^UTILITY(U,$J,358.4,1006,0)
;;=NEW PT-OFFICE^2^76
;;^UTILITY(U,$J,358.4,1007,0)
;;=ESTABLISHED PT-OFFICE^1^76
;;^UTILITY(U,$J,358.4,1008,0)
;;=CONSULTATIONS^3^76
;;^UTILITY(U,$J,358.4,1009,0)
;;=HOME VISIT-EST PT^4^76
;;^UTILITY(U,$J,358.4,1010,0)
;;=HOME VISIT-NEW PT^5^76
;;^UTILITY(U,$J,358.4,1011,0)
;;=CARDIOVASCULAR^2^77
;;^UTILITY(U,$J,358.4,1012,0)
;;=EXTERNAL CAUSES (SECONDARY DX ONLY)^3^77
;;^UTILITY(U,$J,358.4,1013,0)
;;=MENTAL HEALTH^4^77
;;^UTILITY(U,$J,358.4,1014,0)
;;=MUSCULOSKELETAL^5^77
;;^UTILITY(U,$J,358.4,1015,0)
;;=NEPHRO/GU/GI^6^77
;;^UTILITY(U,$J,358.4,1016,0)
;;=PARAPLEGIA^8^77
;;^UTILITY(U,$J,358.4,1017,0)
;;=QUADRAPLEGIA^9^77
;;^UTILITY(U,$J,358.4,1018,0)
;;=ULCERS^13^77
;;^UTILITY(U,$J,358.4,1019,0)
;;=OTHER HEALTH STATUS FACTORS^7^77
;;^UTILITY(U,$J,358.4,1020,0)
;;=COMMON DIAGNOSES^1^77
;;^UTILITY(U,$J,358.4,1021,0)
;;=SUICIDAL IDEATIONS/ATTEMPTS^12^77
;;^UTILITY(U,$J,358.4,1022,0)
;;=SPORT PARTICIPATION^11^77
;;^UTILITY(U,$J,358.4,1023,0)
;;=SPASM OF MUSCLE (SPASTICITY)^10^77
;;^UTILITY(U,$J,358.4,1024,0)
;;=MD/NP/PA ^1^78
;;^UTILITY(U,$J,358.4,1025,0)
;;=RN/LPN/SW/OTH HC PROF^2^78
;;^UTILITY(U,$J,358.4,1026,0)
;;=COMMON DIAGNOSES^1^79
;;^UTILITY(U,$J,358.4,1027,0)
;;=BODY MASS INDEX^3^79
;;^UTILITY(U,$J,358.4,1028,0)
;;=OBESITY^5^79
;;^UTILITY(U,$J,358.4,1029,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^6^79
;;^UTILITY(U,$J,358.4,1030,0)
;;=ANTICOAGULATION^2^79
;;^UTILITY(U,$J,358.4,1031,0)
;;=EYE^4^79
;;^UTILITY(U,$J,358.4,1032,0)
;;=TELE-EYE PROCEDURES^1^80
;;^UTILITY(U,$J,358.4,1033,0)
;;=LOW VISION / BLINDNESS^21^81
;;^UTILITY(U,$J,358.4,1034,0)
;;=RETINA - VASCULAR^12^81
;;^UTILITY(U,$J,358.4,1035,0)
;;=EYELIDS / LASHES^2^81
;;^UTILITY(U,$J,358.4,1036,0)
;;=NEURO / STRABISMUS^18^81
;;^UTILITY(U,$J,358.4,1037,0)
;;=ORBIT - PLASTICS^20^81
;;^UTILITY(U,$J,358.4,1038,0)
;;=VITREOUS^17^81
;;^UTILITY(U,$J,358.4,1039,0)
;;=ORBIT - TRAUMA^19^81
;;^UTILITY(U,$J,358.4,1040,0)
;;=LACRIMAL / NLD / NEOPLASMS^3^81
;;^UTILITY(U,$J,358.4,1041,0)
;;=MOST FREQUENT^1^81
;;^UTILITY(U,$J,358.4,1042,0)
;;=CONJUNCTIVA / SCLERA^4^81
;;^UTILITY(U,$J,358.4,1043,0)
;;=CORNEA / ULCER^5^81
;;^UTILITY(U,$J,358.4,1044,0)
;;=LENS / CATARACT / POSTOP^6^81
;;^UTILITY(U,$J,358.4,1045,0)
;;=IRIS / UVEITIS^7^81
;;^UTILITY(U,$J,358.4,1046,0)
;;=GLAUCOMA - OPEN ANGLE^8^81
;;^UTILITY(U,$J,358.4,1047,0)
;;=GLAUCOMA - CLOSED ANGLE^9^81
;;^UTILITY(U,$J,358.4,1048,0)
;;=GLAUCOMA - SECONDARY^10^81
;;^UTILITY(U,$J,358.4,1049,0)
;;=RETINA - CHOROID / TUMORS / INFLAM^14^81
;;^UTILITY(U,$J,358.4,1050,0)
;;=RETINA - TEAR / PERIPH / DEGENERATION^15^81
;;^UTILITY(U,$J,358.4,1051,0)
;;=RETINA - MACULA^11^81
;;^UTILITY(U,$J,358.4,1052,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^23^81
;;^UTILITY(U,$J,358.4,1053,0)
;;=PMH / OTHER^22^81
;;^UTILITY(U,$J,358.4,1054,0)
;;=RETINA - VEGF INJECT DX CODES^16^81
;;^UTILITY(U,$J,358.4,1055,0)
;;=RETINA - DIABETIC RETINOPATHY^13^81
;;^UTILITY(U,$J,358.4,1056,0)
;;=COVID-19 & RELATED^24^81
;;^UTILITY(U,$J,358.4,1057,0)
;;=PRE-OP VISIT^1^82
;;^UTILITY(U,$J,358.4,1058,0)
;;=CONSULTATION-CLINICIAN^2^82
;;^UTILITY(U,$J,358.4,1059,0)
;;=POST-OP VISIT^4^82
;;^UTILITY(U,$J,358.4,1060,0)
;;=NEW PATIENT^3^82
;;^UTILITY(U,$J,358.4,1061,0)
;;=A DIAGNOSIS^1^83
;;^UTILITY(U,$J,358.4,1062,0)
;;=B DIAGNOSIS^2^83
;;^UTILITY(U,$J,358.4,1063,0)
;;=C DIAGNOSIS^3^83
;;^UTILITY(U,$J,358.4,1064,0)
;;=CANCER (NOT MELANOMA)^4^83
;;^UTILITY(U,$J,358.4,1065,0)
;;=D DIAGNOSIS^5^83
;;^UTILITY(U,$J,358.4,1066,0)
;;=E/F DIAGNOSIS^6^83
;;^UTILITY(U,$J,358.4,1067,0)
;;=G DIAGNOSIS^7^83
;;^UTILITY(U,$J,358.4,1068,0)
;;=H DIAGNOSIS^8^83
;;^UTILITY(U,$J,358.4,1069,0)
;;=I DIAGNOSIS^9^83
;;^UTILITY(U,$J,358.4,1070,0)
;;=J/K/L DIAGNOSIS^10^83
;;^UTILITY(U,$J,358.4,1071,0)
;;=M DIAGNOSIS^11^83
;;^UTILITY(U,$J,358.4,1072,0)
;;=N/O DIAGNOSIS^12^83
;;^UTILITY(U,$J,358.4,1073,0)
;;=P DIAGNOSIS^13^83
;;^UTILITY(U,$J,358.4,1074,0)
;;=R DIAGNOSIS^15^83
;;^UTILITY(U,$J,358.4,1075,0)
;;=S DIAGNOSIS^16^83
;;^UTILITY(U,$J,358.4,1076,0)
;;=T/U DIAGNOSIS^18^83
;;^UTILITY(U,$J,358.4,1077,0)
;;=V/W/X/Y/Z DIAGNOSIS^18^83
;;^UTILITY(U,$J,358.4,1078,0)
;;=PRE-OP,POST-OP,COUNSELING^14^83
;;^UTILITY(U,$J,358.4,1079,0)
;;=SUICIDE IDEATION/ATTEMPT^17^83
;;^UTILITY(U,$J,358.4,1080,0)
;;=NERVE BLOCK^13^84
;;^UTILITY(U,$J,358.4,1081,0)
;;=CATH^2^84
;;^UTILITY(U,$J,358.4,1082,0)
;;=CVA DEVICE^4^84
;;^UTILITY(U,$J,358.4,1083,0)
;;=EPIDURAL^5^84
;;^UTILITY(U,$J,358.4,1084,0)
;;=FOREARM/WRIST/HAND^6^84
;;^UTILITY(U,$J,358.4,1085,0)
;;=HEAD^6^84
;;^UTILITY(U,$J,358.4,1086,0)
;;=INTRATHORACIC^8^84
;;^UTILITY(U,$J,358.4,1087,0)
;;=IV^9^84
;;^UTILITY(U,$J,358.4,1088,0)
;;=LOWER ABDOMEN^10^84
;;^UTILITY(U,$J,358.4,1089,0)
;;=LOWER LEG^11^84
;;^UTILITY(U,$J,358.4,1090,0)
;;=NECK^12^84
;;^UTILITY(U,$J,358.4,1091,0)
;;=ARTERIAL^1^84
;;^UTILITY(U,$J,358.4,1092,0)
;;=OTHER^14^84
;;^UTILITY(U,$J,358.4,1093,0)
;;=PELVIS^15^84
;;^UTILITY(U,$J,358.4,1094,0)
;;=RADIOLOGICAL PROCEDURE^17^84
;;^UTILITY(U,$J,358.4,1095,0)
;;=SHOULDER/AXILLA^18^84
;;^UTILITY(U,$J,358.4,1096,0)
;;=SPINAL NERVES^19^84
;;^UTILITY(U,$J,358.4,1097,0)
;;=SPINE/SPINAL CORD^20^84
;;^UTILITY(U,$J,358.4,1098,0)
;;=TEE^22^84
;;^UTILITY(U,$J,358.4,1099,0)
;;=THORAX^23^84
;;^UTILITY(U,$J,358.4,1100,0)
;;=UPPER ABDOMEN^24^84
;;^UTILITY(U,$J,358.4,1101,0)
;;=UPPER ARM/ELBOW^25^84
;;^UTILITY(U,$J,358.4,1102,0)
;;=UPPER LEG^26^84
;;^UTILITY(U,$J,358.4,1103,0)
;;=CRITICAL CARE^3^84
;;^UTILITY(U,$J,358.4,1104,0)
;;=INJECT-SPINE^7^84
;;^UTILITY(U,$J,358.4,1105,0)
;;=QUALIFYING CIRCUMSTANCES^16^84
;;^UTILITY(U,$J,358.4,1106,0)
;;=TEAM CONFERENCE^21^84
;;^UTILITY(U,$J,358.4,1107,0)
;;=VAGINA^27^84
;;^UTILITY(U,$J,358.4,1108,0)
;;=HOSPICE CARE SUPERVISION^2^85
;;^UTILITY(U,$J,358.4,1109,0)
;;=PROLONGED SERVICES^3^85
;;^UTILITY(U,$J,358.4,1110,0)
;;=ADVANCE CARE PLANNING^1^85
;;^UTILITY(U,$J,358.4,1111,0)
;;=TEAM CONFERENCE^4^85
;;^UTILITY(U,$J,358.4,1112,0)
;;=NEOPLASMS^9^86
;;^UTILITY(U,$J,358.4,1113,0)
;;=CARDIOVASCULAR DISORDERS^2^86
;;^UTILITY(U,$J,358.4,1114,0)
;;=MENTAL HEALTH^8^86
;;^UTILITY(U,$J,358.4,1115,0)
;;=NEUROLOGICAL CONDITIONS^10^86
;;^UTILITY(U,$J,358.4,1116,0)
;;=GI DISORDERS^5^86
;;^UTILITY(U,$J,358.4,1117,0)
;;=LIVER DISORDERS^7^86
;;^UTILITY(U,$J,358.4,1118,0)
;;=KIDNEY DISORDERS^6^86
;;^UTILITY(U,$J,358.4,1119,0)
;;=RESPIRATORY DISORDERS^11^86
;;^UTILITY(U,$J,358.4,1120,0)
;;=PALLIATIVE/HOSPICE ENCOUNTER^1^86
;;^UTILITY(U,$J,358.4,1121,0)
;;=OTHER CONDITIONS^13^86
;;^UTILITY(U,$J,358.4,1122,0)
;;=DEMENTIA^3^86
;;^UTILITY(U,$J,358.4,1123,0)
;;=GENERAL IM^4^86
;;^UTILITY(U,$J,358.4,1124,0)
;;=OTHER BACTERIAL DISEASES^12^86
;;^UTILITY(U,$J,358.4,1125,0)
;;=INPATIENT CONSULTATIONS^1^87
;;^UTILITY(U,$J,358.4,1126,0)
;;=INITIAL INPATIENT CARE^2^87
;;^UTILITY(U,$J,358.4,1127,0)
;;=SUBSEQUENT INPATIENT CARE^3^87
;;^UTILITY(U,$J,358.4,1128,0)
;;=DISCHARGE/PRONOUNCEMENT^4^87
;;^UTILITY(U,$J,358.4,1129,0)
;;=NH INITIAL INPATIENT CARE^5^87
;;^UTILITY(U,$J,358.4,1130,0)
;;=NH SUBSEQUENT INPATIENT CARE^6^87
;;^UTILITY(U,$J,358.4,1131,0)
;;=NH DISCHARGE/PRONOUNCEMENT^7^87
;;^UTILITY(U,$J,358.4,1132,0)
;;=HOSPICE CARE SUPERVISION^4^88
;;^UTILITY(U,$J,358.4,1133,0)
;;=ADVANCE LIFE PLANNING^2^88
;;^UTILITY(U,$J,358.4,1134,0)
;;=EDUCATION^3^88
;;^UTILITY(U,$J,358.4,1135,0)
;;=NON-VIDEO MONITORING^5^88
;;^UTILITY(U,$J,358.4,1136,0)
;;=TEAM CONFERENCE^7^88
;;^UTILITY(U,$J,358.4,1137,0)
;;=PROLONGED SERVICES^6^88
;;^UTILITY(U,$J,358.4,1138,0)
;;=ADVANCE CARE PLANNING^1^88
;;^UTILITY(U,$J,358.4,1139,0)
;;=NEW PATIENT ^2^89
;;^UTILITY(U,$J,358.4,1140,0)
;;=ESTABLISHED PATIENT ^1^89
;;^UTILITY(U,$J,358.4,1141,0)
;;=CONSULTATIONS ^3^89
;;^UTILITY(U,$J,358.4,1142,0)
;;=NEOPLASMS^9^90
;;^UTILITY(U,$J,358.4,1143,0)
;;=CARDIOVASCULAR DISORDERS^2^90
;;^UTILITY(U,$J,358.4,1144,0)
;;=MENTAL HEALTH^8^90
;;^UTILITY(U,$J,358.4,1145,0)
;;=NEUROLOGICAL CONDITIONS^10^90
;;^UTILITY(U,$J,358.4,1146,0)
;;=GI DISORDERS^5^90
;;^UTILITY(U,$J,358.4,1147,0)
;;=LIVER DISORDERS^7^90
;;^UTILITY(U,$J,358.4,1148,0)
;;=KIDNEY DISORDERS^6^90
;;^UTILITY(U,$J,358.4,1149,0)
;;=RESPIRATORY DISORDERS^11^90
;;^UTILITY(U,$J,358.4,1150,0)
;;=PALLIATIVE/HOSPICE ENCOUNTER^1^90
;;^UTILITY(U,$J,358.4,1151,0)
;;=OTHER CONDITIONS^13^90
;;^UTILITY(U,$J,358.4,1152,0)
;;=DEMENTIA^3^90
;;^UTILITY(U,$J,358.4,1153,0)
;;=GENERAL IM^4^90
;;^UTILITY(U,$J,358.4,1154,0)
;;=OTHER BACTERIAL DISEASES^12^90
;;^UTILITY(U,$J,358.4,1155,0)
;;=COVID-19 CONFIRMED^2^91
;;^UTILITY(U,$J,358.4,1156,0)
;;=COVID-19 EXPOSURE^3^91
;;^UTILITY(U,$J,358.4,1157,0)
;;=COVID-19 RELATED COND/SYMP^5^91
;;^UTILITY(U,$J,358.4,1158,0)
;;=COVID-19 SCREEN^1^91
;;^UTILITY(U,$J,358.4,1159,0)
;;=COVID-19 PRE-OP^4^91
;;^UTILITY(U,$J,358.4,1160,0)
;;=COVID-19 VACCINE STATUS^6^91
;;^UTILITY(U,$J,358.4,1161,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^7^91
;;^UTILITY(U,$J,358.4,1162,0)
;;=COVID-19 ^1^92
;;^UTILITY(U,$J,358.4,1163,0)
;;=COVID-19 CONFIRMED^2^93
;;^UTILITY(U,$J,358.4,1164,0)
;;=COVID-19 EXPOSURE^3^93
;;^UTILITY(U,$J,358.4,1165,0)
;;=COVID-19 RELATED COND/SYMP^5^93
;;^UTILITY(U,$J,358.4,1166,0)
;;=COVID-19 SCREEN^1^93
;;^UTILITY(U,$J,358.4,1167,0)
;;=COVID-19 PRE-OP^4^93
;;^UTILITY(U,$J,358.4,1168,0)
;;=COVID-19 VACCINE STATUS^6^93
;;^UTILITY(U,$J,358.4,1169,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^7^93
;;^UTILITY(U,$J,358.4,1178,0)
;;=REMOTE MONITORING^1^96
;;^UTILITY(U,$J,358.4,1179,0)
;;=ONLINE DIGITAL E/M-NONPROVIDER^3^96
;;^UTILITY(U,$J,358.4,1180,0)
;;=ONLINE DIGITAL E/M-PROVIDER^2^96
;;^UTILITY(U,$J,358.4,1181,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^2^97
;;^UTILITY(U,$J,358.4,1182,0)
;;=DIABETES MELLITUS^1^97
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0BH 11943 printed Apr 09, 2024@21:20:33 Page 2
IBDEI0BH ; ; 01-AUG-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4,979,0)
+2 ;;=INFECTIOUS DISEASE^10^74
+3 ;;^UTILITY(U,$J,358.4,980,0)
+4 ;;=INTERSTITIAL LUNG DISEASE^11^74
+5 ;;^UTILITY(U,$J,358.4,981,0)
+6 ;;=MUSCULOSKELETAL^12^74
+7 ;;^UTILITY(U,$J,358.4,982,0)
+8 ;;=SUTURES^24^74
+9 ;;^UTILITY(U,$J,358.4,983,0)
+10 ;;=RADIATION^20^74
+11 ;;^UTILITY(U,$J,358.4,984,0)
+12 ;;=OCCUPATIONAL^16^74
+13 ;;^UTILITY(U,$J,358.4,985,0)
+14 ;;=PAIN^17^74
+15 ;;^UTILITY(U,$J,358.4,986,0)
+16 ;;=PLEURAL DISEASE^18^74
+17 ;;^UTILITY(U,$J,358.4,987,0)
+18 ;;=PSYCHIATRIC/BEHAVIORAL^19^74
+19 ;;^UTILITY(U,$J,358.4,988,0)
+20 ;;=SKIN^21^74
+21 ;;^UTILITY(U,$J,358.4,989,0)
+22 ;;=NEUROLOGIC^13^74
+23 ;;^UTILITY(U,$J,358.4,990,0)
+24 ;;=OBSTRUCTIVE DISEASE^14^74
+25 ;;^UTILITY(U,$J,358.4,991,0)
+26 ;;=VASCULAR^26^74
+27 ;;^UTILITY(U,$J,358.4,992,0)
+28 ;;=SYMPTOMS^25^74
+29 ;;^UTILITY(U,$J,358.4,993,0)
+30 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^74
+31 ;;^UTILITY(U,$J,358.4,994,0)
+32 ;;=VACCINATIONS^12^75
+33 ;;^UTILITY(U,$J,358.4,995,0)
+34 ;;=INJECTION^5^75
+35 ;;^UTILITY(U,$J,358.4,996,0)
+36 ;;=EDUCATION/TRAINING^3^75
+37 ;;^UTILITY(U,$J,358.4,997,0)
+38 ;;=COUNSELING^2^75
+39 ;;^UTILITY(U,$J,358.4,998,0)
+40 ;;=EVALUATIONS^4^75
+41 ;;^UTILITY(U,$J,358.4,999,0)
+42 ;;=SPINAL INJECTION CODES^8^75
+43 ;;^UTILITY(U,$J,358.4,1000,0)
+44 ;;=SUPPLIES^9^75
+45 ;;^UTILITY(U,$J,358.4,1001,0)
+46 ;;=TREATMENT PROCEDURES^10^75
+47 ;;^UTILITY(U,$J,358.4,1002,0)
+48 ;;=TRIGGER POINT INJECTIONS^11^75
+49 ;;^UTILITY(U,$J,358.4,1003,0)
+50 ;;=ACUPUNCTURE^1^75
+51 ;;^UTILITY(U,$J,358.4,1004,0)
+52 ;;=NAILS^7^75
+53 ;;^UTILITY(U,$J,358.4,1005,0)
+54 ;;=INTRATHECAL BACLOFED PUMP REFILL/ADJ^6^75
+55 ;;^UTILITY(U,$J,358.4,1006,0)
+56 ;;=NEW PT-OFFICE^2^76
+57 ;;^UTILITY(U,$J,358.4,1007,0)
+58 ;;=ESTABLISHED PT-OFFICE^1^76
+59 ;;^UTILITY(U,$J,358.4,1008,0)
+60 ;;=CONSULTATIONS^3^76
+61 ;;^UTILITY(U,$J,358.4,1009,0)
+62 ;;=HOME VISIT-EST PT^4^76
+63 ;;^UTILITY(U,$J,358.4,1010,0)
+64 ;;=HOME VISIT-NEW PT^5^76
+65 ;;^UTILITY(U,$J,358.4,1011,0)
+66 ;;=CARDIOVASCULAR^2^77
+67 ;;^UTILITY(U,$J,358.4,1012,0)
+68 ;;=EXTERNAL CAUSES (SECONDARY DX ONLY)^3^77
+69 ;;^UTILITY(U,$J,358.4,1013,0)
+70 ;;=MENTAL HEALTH^4^77
+71 ;;^UTILITY(U,$J,358.4,1014,0)
+72 ;;=MUSCULOSKELETAL^5^77
+73 ;;^UTILITY(U,$J,358.4,1015,0)
+74 ;;=NEPHRO/GU/GI^6^77
+75 ;;^UTILITY(U,$J,358.4,1016,0)
+76 ;;=PARAPLEGIA^8^77
+77 ;;^UTILITY(U,$J,358.4,1017,0)
+78 ;;=QUADRAPLEGIA^9^77
+79 ;;^UTILITY(U,$J,358.4,1018,0)
+80 ;;=ULCERS^13^77
+81 ;;^UTILITY(U,$J,358.4,1019,0)
+82 ;;=OTHER HEALTH STATUS FACTORS^7^77
+83 ;;^UTILITY(U,$J,358.4,1020,0)
+84 ;;=COMMON DIAGNOSES^1^77
+85 ;;^UTILITY(U,$J,358.4,1021,0)
+86 ;;=SUICIDAL IDEATIONS/ATTEMPTS^12^77
+87 ;;^UTILITY(U,$J,358.4,1022,0)
+88 ;;=SPORT PARTICIPATION^11^77
+89 ;;^UTILITY(U,$J,358.4,1023,0)
+90 ;;=SPASM OF MUSCLE (SPASTICITY)^10^77
+91 ;;^UTILITY(U,$J,358.4,1024,0)
+92 ;;=MD/NP/PA ^1^78
+93 ;;^UTILITY(U,$J,358.4,1025,0)
+94 ;;=RN/LPN/SW/OTH HC PROF^2^78
+95 ;;^UTILITY(U,$J,358.4,1026,0)
+96 ;;=COMMON DIAGNOSES^1^79
+97 ;;^UTILITY(U,$J,358.4,1027,0)
+98 ;;=BODY MASS INDEX^3^79
+99 ;;^UTILITY(U,$J,358.4,1028,0)
+100 ;;=OBESITY^5^79
+101 ;;^UTILITY(U,$J,358.4,1029,0)
+102 ;;=SUICIDE IDEATIONS/ATTEMPTS^6^79
+103 ;;^UTILITY(U,$J,358.4,1030,0)
+104 ;;=ANTICOAGULATION^2^79
+105 ;;^UTILITY(U,$J,358.4,1031,0)
+106 ;;=EYE^4^79
+107 ;;^UTILITY(U,$J,358.4,1032,0)
+108 ;;=TELE-EYE PROCEDURES^1^80
+109 ;;^UTILITY(U,$J,358.4,1033,0)
+110 ;;=LOW VISION / BLINDNESS^21^81
+111 ;;^UTILITY(U,$J,358.4,1034,0)
+112 ;;=RETINA - VASCULAR^12^81
+113 ;;^UTILITY(U,$J,358.4,1035,0)
+114 ;;=EYELIDS / LASHES^2^81
+115 ;;^UTILITY(U,$J,358.4,1036,0)
+116 ;;=NEURO / STRABISMUS^18^81
+117 ;;^UTILITY(U,$J,358.4,1037,0)
+118 ;;=ORBIT - PLASTICS^20^81
+119 ;;^UTILITY(U,$J,358.4,1038,0)
+120 ;;=VITREOUS^17^81
+121 ;;^UTILITY(U,$J,358.4,1039,0)
+122 ;;=ORBIT - TRAUMA^19^81
+123 ;;^UTILITY(U,$J,358.4,1040,0)
+124 ;;=LACRIMAL / NLD / NEOPLASMS^3^81
+125 ;;^UTILITY(U,$J,358.4,1041,0)
+126 ;;=MOST FREQUENT^1^81
+127 ;;^UTILITY(U,$J,358.4,1042,0)
+128 ;;=CONJUNCTIVA / SCLERA^4^81
+129 ;;^UTILITY(U,$J,358.4,1043,0)
+130 ;;=CORNEA / ULCER^5^81
+131 ;;^UTILITY(U,$J,358.4,1044,0)
+132 ;;=LENS / CATARACT / POSTOP^6^81
+133 ;;^UTILITY(U,$J,358.4,1045,0)
+134 ;;=IRIS / UVEITIS^7^81
+135 ;;^UTILITY(U,$J,358.4,1046,0)
+136 ;;=GLAUCOMA - OPEN ANGLE^8^81
+137 ;;^UTILITY(U,$J,358.4,1047,0)
+138 ;;=GLAUCOMA - CLOSED ANGLE^9^81
+139 ;;^UTILITY(U,$J,358.4,1048,0)
+140 ;;=GLAUCOMA - SECONDARY^10^81
+141 ;;^UTILITY(U,$J,358.4,1049,0)
+142 ;;=RETINA - CHOROID / TUMORS / INFLAM^14^81
+143 ;;^UTILITY(U,$J,358.4,1050,0)
+144 ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^81
+145 ;;^UTILITY(U,$J,358.4,1051,0)
+146 ;;=RETINA - MACULA^11^81
+147 ;;^UTILITY(U,$J,358.4,1052,0)
+148 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^81
+149 ;;^UTILITY(U,$J,358.4,1053,0)
+150 ;;=PMH / OTHER^22^81
+151 ;;^UTILITY(U,$J,358.4,1054,0)
+152 ;;=RETINA - VEGF INJECT DX CODES^16^81
+153 ;;^UTILITY(U,$J,358.4,1055,0)
+154 ;;=RETINA - DIABETIC RETINOPATHY^13^81
+155 ;;^UTILITY(U,$J,358.4,1056,0)
+156 ;;=COVID-19 & RELATED^24^81
+157 ;;^UTILITY(U,$J,358.4,1057,0)
+158 ;;=PRE-OP VISIT^1^82
+159 ;;^UTILITY(U,$J,358.4,1058,0)
+160 ;;=CONSULTATION-CLINICIAN^2^82
+161 ;;^UTILITY(U,$J,358.4,1059,0)
+162 ;;=POST-OP VISIT^4^82
+163 ;;^UTILITY(U,$J,358.4,1060,0)
+164 ;;=NEW PATIENT^3^82
+165 ;;^UTILITY(U,$J,358.4,1061,0)
+166 ;;=A DIAGNOSIS^1^83
+167 ;;^UTILITY(U,$J,358.4,1062,0)
+168 ;;=B DIAGNOSIS^2^83
+169 ;;^UTILITY(U,$J,358.4,1063,0)
+170 ;;=C DIAGNOSIS^3^83
+171 ;;^UTILITY(U,$J,358.4,1064,0)
+172 ;;=CANCER (NOT MELANOMA)^4^83
+173 ;;^UTILITY(U,$J,358.4,1065,0)
+174 ;;=D DIAGNOSIS^5^83
+175 ;;^UTILITY(U,$J,358.4,1066,0)
+176 ;;=E/F DIAGNOSIS^6^83
+177 ;;^UTILITY(U,$J,358.4,1067,0)
+178 ;;=G DIAGNOSIS^7^83
+179 ;;^UTILITY(U,$J,358.4,1068,0)
+180 ;;=H DIAGNOSIS^8^83
+181 ;;^UTILITY(U,$J,358.4,1069,0)
+182 ;;=I DIAGNOSIS^9^83
+183 ;;^UTILITY(U,$J,358.4,1070,0)
+184 ;;=J/K/L DIAGNOSIS^10^83
+185 ;;^UTILITY(U,$J,358.4,1071,0)
+186 ;;=M DIAGNOSIS^11^83
+187 ;;^UTILITY(U,$J,358.4,1072,0)
+188 ;;=N/O DIAGNOSIS^12^83
+189 ;;^UTILITY(U,$J,358.4,1073,0)
+190 ;;=P DIAGNOSIS^13^83
+191 ;;^UTILITY(U,$J,358.4,1074,0)
+192 ;;=R DIAGNOSIS^15^83
+193 ;;^UTILITY(U,$J,358.4,1075,0)
+194 ;;=S DIAGNOSIS^16^83
+195 ;;^UTILITY(U,$J,358.4,1076,0)
+196 ;;=T/U DIAGNOSIS^18^83
+197 ;;^UTILITY(U,$J,358.4,1077,0)
+198 ;;=V/W/X/Y/Z DIAGNOSIS^18^83
+199 ;;^UTILITY(U,$J,358.4,1078,0)
+200 ;;=PRE-OP,POST-OP,COUNSELING^14^83
+201 ;;^UTILITY(U,$J,358.4,1079,0)
+202 ;;=SUICIDE IDEATION/ATTEMPT^17^83
+203 ;;^UTILITY(U,$J,358.4,1080,0)
+204 ;;=NERVE BLOCK^13^84
+205 ;;^UTILITY(U,$J,358.4,1081,0)
+206 ;;=CATH^2^84
+207 ;;^UTILITY(U,$J,358.4,1082,0)
+208 ;;=CVA DEVICE^4^84
+209 ;;^UTILITY(U,$J,358.4,1083,0)
+210 ;;=EPIDURAL^5^84
+211 ;;^UTILITY(U,$J,358.4,1084,0)
+212 ;;=FOREARM/WRIST/HAND^6^84
+213 ;;^UTILITY(U,$J,358.4,1085,0)
+214 ;;=HEAD^6^84
+215 ;;^UTILITY(U,$J,358.4,1086,0)
+216 ;;=INTRATHORACIC^8^84
+217 ;;^UTILITY(U,$J,358.4,1087,0)
+218 ;;=IV^9^84
+219 ;;^UTILITY(U,$J,358.4,1088,0)
+220 ;;=LOWER ABDOMEN^10^84
+221 ;;^UTILITY(U,$J,358.4,1089,0)
+222 ;;=LOWER LEG^11^84
+223 ;;^UTILITY(U,$J,358.4,1090,0)
+224 ;;=NECK^12^84
+225 ;;^UTILITY(U,$J,358.4,1091,0)
+226 ;;=ARTERIAL^1^84
+227 ;;^UTILITY(U,$J,358.4,1092,0)
+228 ;;=OTHER^14^84
+229 ;;^UTILITY(U,$J,358.4,1093,0)
+230 ;;=PELVIS^15^84
+231 ;;^UTILITY(U,$J,358.4,1094,0)
+232 ;;=RADIOLOGICAL PROCEDURE^17^84
+233 ;;^UTILITY(U,$J,358.4,1095,0)
+234 ;;=SHOULDER/AXILLA^18^84
+235 ;;^UTILITY(U,$J,358.4,1096,0)
+236 ;;=SPINAL NERVES^19^84
+237 ;;^UTILITY(U,$J,358.4,1097,0)
+238 ;;=SPINE/SPINAL CORD^20^84
+239 ;;^UTILITY(U,$J,358.4,1098,0)
+240 ;;=TEE^22^84
+241 ;;^UTILITY(U,$J,358.4,1099,0)
+242 ;;=THORAX^23^84
+243 ;;^UTILITY(U,$J,358.4,1100,0)
+244 ;;=UPPER ABDOMEN^24^84
+245 ;;^UTILITY(U,$J,358.4,1101,0)
+246 ;;=UPPER ARM/ELBOW^25^84
+247 ;;^UTILITY(U,$J,358.4,1102,0)
+248 ;;=UPPER LEG^26^84
+249 ;;^UTILITY(U,$J,358.4,1103,0)
+250 ;;=CRITICAL CARE^3^84
+251 ;;^UTILITY(U,$J,358.4,1104,0)
+252 ;;=INJECT-SPINE^7^84
+253 ;;^UTILITY(U,$J,358.4,1105,0)
+254 ;;=QUALIFYING CIRCUMSTANCES^16^84
+255 ;;^UTILITY(U,$J,358.4,1106,0)
+256 ;;=TEAM CONFERENCE^21^84
+257 ;;^UTILITY(U,$J,358.4,1107,0)
+258 ;;=VAGINA^27^84
+259 ;;^UTILITY(U,$J,358.4,1108,0)
+260 ;;=HOSPICE CARE SUPERVISION^2^85
+261 ;;^UTILITY(U,$J,358.4,1109,0)
+262 ;;=PROLONGED SERVICES^3^85
+263 ;;^UTILITY(U,$J,358.4,1110,0)
+264 ;;=ADVANCE CARE PLANNING^1^85
+265 ;;^UTILITY(U,$J,358.4,1111,0)
+266 ;;=TEAM CONFERENCE^4^85
+267 ;;^UTILITY(U,$J,358.4,1112,0)
+268 ;;=NEOPLASMS^9^86
+269 ;;^UTILITY(U,$J,358.4,1113,0)
+270 ;;=CARDIOVASCULAR DISORDERS^2^86
+271 ;;^UTILITY(U,$J,358.4,1114,0)
+272 ;;=MENTAL HEALTH^8^86
+273 ;;^UTILITY(U,$J,358.4,1115,0)
+274 ;;=NEUROLOGICAL CONDITIONS^10^86
+275 ;;^UTILITY(U,$J,358.4,1116,0)
+276 ;;=GI DISORDERS^5^86
+277 ;;^UTILITY(U,$J,358.4,1117,0)
+278 ;;=LIVER DISORDERS^7^86
+279 ;;^UTILITY(U,$J,358.4,1118,0)
+280 ;;=KIDNEY DISORDERS^6^86
+281 ;;^UTILITY(U,$J,358.4,1119,0)
+282 ;;=RESPIRATORY DISORDERS^11^86
+283 ;;^UTILITY(U,$J,358.4,1120,0)
+284 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^86
+285 ;;^UTILITY(U,$J,358.4,1121,0)
+286 ;;=OTHER CONDITIONS^13^86
+287 ;;^UTILITY(U,$J,358.4,1122,0)
+288 ;;=DEMENTIA^3^86
+289 ;;^UTILITY(U,$J,358.4,1123,0)
+290 ;;=GENERAL IM^4^86
+291 ;;^UTILITY(U,$J,358.4,1124,0)
+292 ;;=OTHER BACTERIAL DISEASES^12^86
+293 ;;^UTILITY(U,$J,358.4,1125,0)
+294 ;;=INPATIENT CONSULTATIONS^1^87
+295 ;;^UTILITY(U,$J,358.4,1126,0)
+296 ;;=INITIAL INPATIENT CARE^2^87
+297 ;;^UTILITY(U,$J,358.4,1127,0)
+298 ;;=SUBSEQUENT INPATIENT CARE^3^87
+299 ;;^UTILITY(U,$J,358.4,1128,0)
+300 ;;=DISCHARGE/PRONOUNCEMENT^4^87
+301 ;;^UTILITY(U,$J,358.4,1129,0)
+302 ;;=NH INITIAL INPATIENT CARE^5^87
+303 ;;^UTILITY(U,$J,358.4,1130,0)
+304 ;;=NH SUBSEQUENT INPATIENT CARE^6^87
+305 ;;^UTILITY(U,$J,358.4,1131,0)
+306 ;;=NH DISCHARGE/PRONOUNCEMENT^7^87
+307 ;;^UTILITY(U,$J,358.4,1132,0)
+308 ;;=HOSPICE CARE SUPERVISION^4^88
+309 ;;^UTILITY(U,$J,358.4,1133,0)
+310 ;;=ADVANCE LIFE PLANNING^2^88
+311 ;;^UTILITY(U,$J,358.4,1134,0)
+312 ;;=EDUCATION^3^88
+313 ;;^UTILITY(U,$J,358.4,1135,0)
+314 ;;=NON-VIDEO MONITORING^5^88
+315 ;;^UTILITY(U,$J,358.4,1136,0)
+316 ;;=TEAM CONFERENCE^7^88
+317 ;;^UTILITY(U,$J,358.4,1137,0)
+318 ;;=PROLONGED SERVICES^6^88
+319 ;;^UTILITY(U,$J,358.4,1138,0)
+320 ;;=ADVANCE CARE PLANNING^1^88
+321 ;;^UTILITY(U,$J,358.4,1139,0)
+322 ;;=NEW PATIENT ^2^89
+323 ;;^UTILITY(U,$J,358.4,1140,0)
+324 ;;=ESTABLISHED PATIENT ^1^89
+325 ;;^UTILITY(U,$J,358.4,1141,0)
+326 ;;=CONSULTATIONS ^3^89
+327 ;;^UTILITY(U,$J,358.4,1142,0)
+328 ;;=NEOPLASMS^9^90
+329 ;;^UTILITY(U,$J,358.4,1143,0)
+330 ;;=CARDIOVASCULAR DISORDERS^2^90
+331 ;;^UTILITY(U,$J,358.4,1144,0)
+332 ;;=MENTAL HEALTH^8^90
+333 ;;^UTILITY(U,$J,358.4,1145,0)
+334 ;;=NEUROLOGICAL CONDITIONS^10^90
+335 ;;^UTILITY(U,$J,358.4,1146,0)
+336 ;;=GI DISORDERS^5^90
+337 ;;^UTILITY(U,$J,358.4,1147,0)
+338 ;;=LIVER DISORDERS^7^90
+339 ;;^UTILITY(U,$J,358.4,1148,0)
+340 ;;=KIDNEY DISORDERS^6^90
+341 ;;^UTILITY(U,$J,358.4,1149,0)
+342 ;;=RESPIRATORY DISORDERS^11^90
+343 ;;^UTILITY(U,$J,358.4,1150,0)
+344 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^90
+345 ;;^UTILITY(U,$J,358.4,1151,0)
+346 ;;=OTHER CONDITIONS^13^90
+347 ;;^UTILITY(U,$J,358.4,1152,0)
+348 ;;=DEMENTIA^3^90
+349 ;;^UTILITY(U,$J,358.4,1153,0)
+350 ;;=GENERAL IM^4^90
+351 ;;^UTILITY(U,$J,358.4,1154,0)
+352 ;;=OTHER BACTERIAL DISEASES^12^90
+353 ;;^UTILITY(U,$J,358.4,1155,0)
+354 ;;=COVID-19 CONFIRMED^2^91
+355 ;;^UTILITY(U,$J,358.4,1156,0)
+356 ;;=COVID-19 EXPOSURE^3^91
+357 ;;^UTILITY(U,$J,358.4,1157,0)
+358 ;;=COVID-19 RELATED COND/SYMP^5^91
+359 ;;^UTILITY(U,$J,358.4,1158,0)
+360 ;;=COVID-19 SCREEN^1^91
+361 ;;^UTILITY(U,$J,358.4,1159,0)
+362 ;;=COVID-19 PRE-OP^4^91
+363 ;;^UTILITY(U,$J,358.4,1160,0)
+364 ;;=COVID-19 VACCINE STATUS^6^91
+365 ;;^UTILITY(U,$J,358.4,1161,0)
+366 ;;=SUICIDE IDEATIONS/ATTEMPTS^7^91
+367 ;;^UTILITY(U,$J,358.4,1162,0)
+368 ;;=COVID-19 ^1^92
+369 ;;^UTILITY(U,$J,358.4,1163,0)
+370 ;;=COVID-19 CONFIRMED^2^93
+371 ;;^UTILITY(U,$J,358.4,1164,0)
+372 ;;=COVID-19 EXPOSURE^3^93
+373 ;;^UTILITY(U,$J,358.4,1165,0)
+374 ;;=COVID-19 RELATED COND/SYMP^5^93
+375 ;;^UTILITY(U,$J,358.4,1166,0)
+376 ;;=COVID-19 SCREEN^1^93
+377 ;;^UTILITY(U,$J,358.4,1167,0)
+378 ;;=COVID-19 PRE-OP^4^93
+379 ;;^UTILITY(U,$J,358.4,1168,0)
+380 ;;=COVID-19 VACCINE STATUS^6^93
+381 ;;^UTILITY(U,$J,358.4,1169,0)
+382 ;;=SUICIDE IDEATIONS/ATTEMPTS^7^93
+383 ;;^UTILITY(U,$J,358.4,1178,0)
+384 ;;=REMOTE MONITORING^1^96
+385 ;;^UTILITY(U,$J,358.4,1179,0)
+386 ;;=ONLINE DIGITAL E/M-NONPROVIDER^3^96
+387 ;;^UTILITY(U,$J,358.4,1180,0)
+388 ;;=ONLINE DIGITAL E/M-PROVIDER^2^96
+389 ;;^UTILITY(U,$J,358.4,1181,0)
+390 ;;=SUICIDE IDEATIONS/ATTEMPTS^2^97
+391 ;;^UTILITY(U,$J,358.4,1182,0)
+392 ;;=DIABETES MELLITUS^1^97
